# Randomized, controlled, double‐blinded clinical trial of effect of bevacizumab injection in management of epistaxis in hereditary hemorrhagic telangiectasia patients undergoing surgical cauterization

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-controlled-double-blinded-clinical-trial-of-effect-of-bevacizumab/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ashoke Khanwalkar,Aakanksha Rathor,Amelia K. Read,Hassan Paknezhad,Yifei Ma,Peter H. Hwang |
| Citations | 18 |
| DOI | 10.1002/alr.22961 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4205608388 |
| PMID | 34989143 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Ashoke Khanwalkar](https://scholariq.org/researchers/ashoke-khanwalkar/)

## Paper journal

- [International Forum of Allergy & Rhinology](https://scholariq.org/journals/international-forum-of-allergy-and-rhinology/)

## Paper primary topic

- [Vascular Anomalies and Treatments](https://scholariq.org/topics/vascular-anomalies-and-treatments/)

## Paper topics

- [Vascular Anomalies and Treatments](https://scholariq.org/topics/vascular-anomalies-and-treatments/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)
- [Otitis Media and Relapsing Polychondritis](https://scholariq.org/topics/otitis-media-and-relapsing-polychondritis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.